阿德福韦酯对慢性乙型肝炎患者Th1/Th2型细胞因子的影响

罗芳琼; 潘煜; 刘晶晶; 张鹏; 牛俊奇; 姜艳芳

阿德福韦酯对慢性乙型肝炎患者Th1/Th2型细胞因子的影响

1. 吉林大学第一医院肝胆胰内科
2. 聊城市人民医院感染病科

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2958
- HTML全文浏览量: 7
- PDF下载量: 640
- 被引次数: 0
出版历程
- 出版日期: 2010-01-20

The Impact of Adefovior dipivoxil on Th1/Th2 cytokines in chronic hepatitis B Patients

摘要

摘要: 目的分析细胞因子IFN-γ、TNF-α、IL-10、IL-6、IL-4、IL-2在慢性乙型肝炎患者治疗后血清中的浓度改变及其临床意义。方法应用微阵列流式细胞术（CBA）体外检测慢性乙型肝炎患者治疗前、治疗12周、24周、48周的血清细胞因子IFN-γ、TNF-α、IL-10、IL-6、IL-4、IL-2的浓度。结果慢性乙型肝炎患者阿德福韦酯治疗后外周血清的TH1/TH2细胞因子浓度度,比较治疗前,均是显著升高的（P<0.05）,除IL-6外,各细胞因子在治疗过程中均未有显著变化（P>0.05）;治疗12周时的血清IL-6的浓度与HBVDNA成负相关,治疗24周,IL-6、IL-10、TNF-α与HBVDNA成负相关（P<0.05）。结论阿德福韦酯除直接抑制病毒作用外,还可能通过免疫调节作用抑制病毒复制。
- 慢性乙型肝炎 /
- 细胞因子 /
- 阿德福韦酯 /
- 微阵列流式细胞术
Abstract: Objective To analyze the changes in Th1/Th2 cytokines level in chronic hepatitis B patients during Adefovir dipivoxil therapy.Methods The serum levels of TNF-α, IFN-γ, IL-10, IL-6, IL-4 and IL-2 were measured in chronic hepatitis B (CHB) patients using Cytotoxic Bead Array (CBA) technique.Results After 12, 24, and 48 weeks of treatment, the serum levels of TNF-α, IFN-γ, IL-10, IL-4 and IL-2 in CHB patients were significantly increased compared to the baseline (P < 0.05) .At the 12th week of treatment, IL-6 was negatively correlated with HBV DNA and after 24 weeks of treatment, IL-6, IL-10 and TNF-α were negatively correlated with HBV DNA (P < 0.05) .Conclusion Adefovir dipivoxil may inhibit HBV DNA replication through the immune pathway.
- Chronic Hepatitis B /
- cytokine /
- Adefovir Dipivoxil /
- Cytotoxic Bead Array

HTML全文

参考文献(9)

[1]Jung MC, Hartmann B, Gerlach JT, et al.Virus-specific lympho-kine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection[J].Virology, 1999, 261 (2) ∶165-172.

[2]Barnaba V, Franco A, Paroli M, et al.Selective expansion of cyto-toxic T lymphocytes with a CD4+CD56+surface phenotype and a T helper type1profile of cytokine secretion in The liver of patients chronically infected with Hepatitis B virus[J].J Immunol, 1994, 15 (6) ∶3074-3087.

[3]Raffaele C, Nicoletta V, Emanuela B, et al.Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates[J].Antivir ResVolume Issue, 1994, 23 (1) ∶77-89.

[4]Stoop JN, van der Molen RG., Baan CC, et al.Regulatory T cells contribute to The impaired immune response in patients with chronic hepatitis B virus infection[J].Hepatology, 2005, 41 (4) ∶771-778.

[5]EiriniI R, Deepak S, Shilpa C et al.Lamivudine Plus Interleukin-12Combination Therapy in Chronic Hepatitis B:Antiviral and Immuno-logicalActivity[J].Hepatology, 2005, 42 (5) ∶1028-36.

[6]江军, 缪晓辉, 蔡雄.阿德福韦酯和拉米夫定对慢性乙型肝炎患者IFN-γ和IL-4的影响比较[J].临床肝胆病杂志.2007, 23 (3) ∶176-178.

[7]马萍, 王磊, 王怡, 等.慢性乙型肝炎患者阿德福韦酯治疗前后血清Th1和Th2细胞因子水平变化及其与HBeAg的关系[J].中华实验和临床感染病杂志 (电子版) , 2008, 2 (1) ∶55-58.

[8]Jiang YF, Wang F, Liu YY, et al.The host immunity response of hepatitis B patients after Adefovir dipivoxil and Entecavir therapy[J].Hepatology, 2008, 47 (6) ∶1020.

[9]Kuo TM, Hu CP, Chen YL, et al.HBV replication is significantly reduced by IL-6[J].Journal of Biomedical Science, 2009, 16 (1) ∶41.

施引文献

资源附件(0)

访问统计